Accelerating Biologics Stability Screening with Zetasizer Core. Complete Stability. One platform.

Are you measuring stability, or just one piece of the puzzle?

Early stability decisions can make or break a biologics development program. But fragmented workflows and isolated measurements can slow down candidate selection and formulation development.

Join us for a 1-hour webinar exploring how high-throughput biophysical characterization can bring size, aggregation, colloidal stability, and structural stability together in a single workflow. We’ll introduce the Zetasizer Core platform and show how DLS, SLS, and DSF can provide complementary insights to help identify stability risks earlier and support faster, more confident development decisions.

Discover how a plate-based approach can help you screen more samples, generate richer stability data, and streamline your workflow—from candidate selection and formulation screening to long-term stability studies.

Who should attend?

• Biologics discovery, developability, and formulation, including therapeutic proteins and antibodies.
• Protein characterization, structural biology, and analytical development, looking for faster and more comprehensive stability insights. 
• Quality control, process development, and R&D teams interested in high-throughput sizing, aggregation, and colloidal stability screening.

What will you learn?

• Understand how DLS, SLS, and DSF provide complementary insights into colloidal, physical, and structural stability. 
• Identify key stability indicators — including particle size, aggregation, kD, B22, Tm, and Tagg — and understand how they can support candidate and formulation decisions. 
• Explore how high-throughput, plate-based screening can accelerate biologics development while reducing sample consumption and workflow complexity.

Speaker: Dr. John Stenson (Product Manager, Malvern Panalytical)